Clinical Trial Update: An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV (VENUS-2) [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study evaluating oral BIBF 1120 in combination with intravenous carboplatin and vinorelbine in elderly patients with advanced non-small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BIBF 1120 (nintedanib)
• CARBOPLATIN (Carboplatin)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Aktion Bronchialkarzinom e.V. | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: COMPLETED